Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Asset Utilization Ratio (2020 - 2025)

Historic Asset Utilization Ratio for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to 0.53.

  • Eton Pharmaceuticals' Asset Utilization Ratio fell 6852.98% to 0.53 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.53, marking a year-over-year decrease of 6852.98%. This contributed to the annual value of 0.72 for FY2024, which is 3511.12% down from last year.
  • As of Q3 2025, Eton Pharmaceuticals' Asset Utilization Ratio stood at 0.53, which was down 6852.98% from 0.46 recorded in Q2 2025.
  • In the past 5 years, Eton Pharmaceuticals' Asset Utilization Ratio ranged from a high of 1.82 in Q1 2024 and a low of 0.41 during Q1 2025
  • In the last 5 years, Eton Pharmaceuticals' Asset Utilization Ratio had a median value of 0.74 in 2022 and averaged 0.89.
  • As far as peak fluctuations go, Eton Pharmaceuticals' Asset Utilization Ratio surged by 539733.18% in 2021, and later plummeted by 7742.83% in 2025.
  • Quarter analysis of 5 years shows Eton Pharmaceuticals' Asset Utilization Ratio stood at 0.81 in 2021, then rose by 0.52% to 0.81 in 2022, then surged by 110.81% to 1.71 in 2023, then crashed by 59.28% to 0.7 in 2024, then fell by 23.69% to 0.53 in 2025.
  • Its Asset Utilization Ratio stands at 0.53 for Q3 2025, versus 0.46 for Q2 2025 and 0.41 for Q1 2025.